We are live on ! Find out more
DS

David Shaw D.E. Shaw & Co

AUM $210B
1-Year Est. Return 57.28%
 

David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.

This Fund
S&P 500
This Quarter Est. Return
+3.44%
1 Year Est. Return
+57.28%
3 Year Est. Return
+174.65%
5 Year Est. Return
+213.13%
10 Year Est. Return
+910.08%
AUM
$80.2B
AUM Growth
+$2.8B
Cap. Flow
+$296M
Cap. Flow %
0.37%
Top 10 Hldgs %
9.83%
Holding
4,048
New
499
Increased
1,419
Reduced
1,452
Closed
416

Top Buys

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$667M
2
NVDA icon
NVIDIA
NVDA
+$584M
3
COP icon
ConocoPhillips
COP
+$432M
4
AMZN icon
Amazon
AMZN
+$418M
5
JNJ icon
Johnson & Johnson
JNJ
+$377M

Top Sells

Rank Stock Value
1
QCOM icon
Qualcomm
QCOM
+$836M
2
META icon
Meta Platforms (Facebook)
META
+$525M
3
AAPL icon
Apple
AAPL
+$453M
4
CELG
Celgene Corp
CELG
+$349M
5
PFE icon
Pfizer
PFE
+$306M

Sector Composition

Rank Sector Weight
1 Technology 16.27%
2 Consumer Discretionary 13.7%
3 Healthcare 13.3%
4 Industrials 7.34%
5 Financials 7.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SMRT
3526
DELISTED
Stein Mart Inc
SMRT
$70K ﹤0.01%
+81,538
New +$74.2K
TEN
3527
Tsakos Energy Navigation Ltd
TEN
$1.27B
$69K ﹤0.01%
+4,186
New +$67.3K
CPE
3528
DELISTED
Callon Petroleum Company
CPE
$69K ﹤0.01%
1,042
-255
-20% -$18.4K
ALDX icon
3529
Aldeyra Therapeutics
ALDX
$91.7M
$67K ﹤0.01%
+11,104
New +$83.6K
ORC
3530
Orchid Island Capital
ORC
$1.34B
$65K ﹤0.01%
+2,039
New +$66.2K
VSTM icon
3531
Verastem
VSTM
$624M
$62K ﹤0.01%
3,434
-3,287
-49% -$74.5K
ADXS
3532
DELISTED
Advaxis Inc
ADXS
$62K ﹤0.01%
29,600
+2,743
+10% +$8.69K
NETI
3533
DELISTED
Eneti Inc.
NETI
$60K ﹤0.01%
+1,412
New +$60.3K
ABEO icon
3534
Abeona Therapeutics
ABEO
$347M
$59K ﹤0.01%
+497
New +$83.3K
BTE icon
3535
Baytex Energy
BTE
$3.27B
$59K ﹤0.01%
+37,900
New +$68.8K
VIVS
3536
VivoSim Labs
VIVS
$3.94M
$59K ﹤0.01%
472
-2,705
-85% -$511K
CVRS
3537
DELISTED
CORINDUS VASCULAR ROBOTICS, INC
CVRS
$58K ﹤0.01%
+19,377
New +$48.5K
NEOS
3538
DELISTED
Neos Therapeutics, Inc
NEOS
$57K ﹤0.01%
+43,906
New +$80.8K
BRACW
3539
DELISTED
Black Ridge Acquisition Corp. Warrant
BRACW
$57K ﹤0.01%
138,000
CLDX icon
3540
Celldex Therapeutics
CLDX
$3.2B
$53K ﹤0.01%
19,619
-86,062
-81% -$292K
GORO icon
3541
Goldgroup Mining
GORO
$267M
$53K ﹤0.01%
+15,613
New +$52.9K
FOMX
3542
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$52K ﹤0.01%
21,880
-1,979
-8% -$5.91K
AVDL
3543
DELISTED
Avadel Pharmaceuticals
AVDL
$50K ﹤0.01%
17,425
-16,470
-49% -$28.3K
NOK icon
3544
CALL
Nokia
NOK
$55.5B
$50K ﹤0.01%
+10,000
New +$52.6K
GPOR
3545
PUT
DELISTED
Gulfport Energy Corp.
GPOR
$49K ﹤0.01%
10,000
FRED
3546
DELISTED
Fred's Inc
FRED
$47K ﹤0.01%
95,261
-315,358
-77% -$305K
AHT
3547
Ashford Hospitality Trust
AHT
$21.5M
$45K ﹤0.01%
+15
New +$70.2K
CGEN icon
3548
Compugen
CGEN
$244M
$45K ﹤0.01%
+11,691
New +$41.4K
BW icon
3549
Babcock & Wilcox
BW
$1.16B
$43K ﹤0.01%
12,460
-487,554
-98% -$1.88M
LKSD
3550
DELISTED
LSC Communications, Inc.
LKSD
$43K ﹤0.01%
11,754
-302,711
-96% -$1.78M

Similar funds

David Shaw's Q2 2019 Portfolio in Review

As of Q2 2019, David Shaw held 4,048 positions worth $80.2B, up 3.6% from $77.4B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.

David Shaw's Q2 2019 filing shows 499 new, 1,419 increased, 1,452 reduced and 416 closed positions. Its largest new stake was Zayo Group Holdings, Inc.: 5,926,898 shares worth $195M. The largest sale was Qualcomm, an estimated $836M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • David Shaw's largest Q2 2019 buy was Zayo Group Holdings, Inc.: 5,926,898 shares worth $195M.
  • David Shaw added most to Alibaba in Q2 2019, an estimated $667M increase.
  • David Shaw's biggest Q2 2019 reduction was Qualcomm, cutting an estimated $836M.
  • David Shaw fully exited iShares Core S&P 500 ETF in Q2 2019, selling an estimated $42.7M.
  • David Shaw's ten largest holdings make up 9.8% of its $80.2B portfolio in Q2 2019.
  • David Shaw opened 499 new positions and closed 416 in Q2 2019.
  • David Shaw's portfolio value rose 3.6% quarter-over-quarter to $80.2B.

Based on D.E. Shaw & Co's 13F filing for Q2 2019, filed 14 Aug 2019.